Scarlet Formulation Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 16 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.73 Cr
as on 16-11-2024
- Revenue -15.04%
(FY 2023)
- Profit -25.44%
(FY 2023)
- Ebitda -88.20%
(FY 2023)
- Net Worth 48.80%
(FY 2023)
- Total Assets -7.24%
(FY 2023)
About Scarlet Formulation
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.73 Cr.
Anil Kumar and Ashwani Bhatia serve as directors at the Company.
- CIN/LLPIN
U24232RJ2008PTC027686
- Company No.
027686
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Nov 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Scarlet Formulation?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Kumar  | Additional Director | 14-Nov-2024 | Current |
| Ashwani Bhatia | Additional Director | 14-Nov-2024 | Current |
Financial Performance and Corporate Structure Insights of Scarlet Formulation.
Scarlet Formulation Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.04% decrease. The company also saw a substantial fall in profitability, with a 25.44% decrease in profit. The company's net worth Soared by an impressive increase of 48.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Scarlet Formulation?
In 2022, Scarlet Formulation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Plus Distribution Private LimitedActive 11 years 30 daysAnil Kumar and Ashwani Bhatia are mutual person
- Dynamic Infracity Private LimitedActive 10 years 10 months
Anil Kumar and Ashwani Bhatia are mutual person
- Ruchi Pharma Distributors Private LimitedActive 1 year 7 months
Anil Kumar and Ashwani Bhatia are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 08 Jan 2020 | ₹1.00 Cr | Open |
India Infoline Finance Limited Creation Date: 31 Oct 2013 | ₹1.50 M | Open |
India Infoline Finance Limited Creation Date: 30 Sep 2013 | ₹4.86 M | Open |
How Many Employees Work at Scarlet Formulation?
Unlock and access historical data on people associated with Scarlet Formulation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Scarlet Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scarlet Formulation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
